Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Danchin

Showing results (11-20 of 432) with videos related to

Pageof 44
Sort By:
European Heart Journal|September 2, 2009
Still a long way to go to defeating atherosclerotic disease: a call to arms!Nicolas Danchin
Archives of Cardiovascular Diseases|March 24, 2009
Should angiotensin-converting enzyme inhibitors be used in all patients with coronary artery disease or restricted to those with a history of myocardial infarction or myocardial revascularization?Nicolas Danchin
Heart (British Cardiac Society)|November 4, 2022
Missed opportunities in secondary prevention with statinsNicolas Danchin
European Heart Journal|February 17, 2005
Percutaneous coronary intervention following intravenous fibrinolytic therapy: should it be a must?Nicolas Danchin
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 12, 2018
What should interventional cardiologists do for patients with prediabetes?Nicolas Danchin
Annales De Cardiologie Et D'Angeiologie|January 18, 2006
[Drug combinations and cardiovascular prevention]Nicolas Danchin
JACC. Cardiovascular Interventions|October 24, 2009
Systems of care for ST-segment elevation myocardial infarction: impact of different models on clinical outcomesNicolas Danchin
La Revue Du Praticien|May 17, 2003
[Clinical aspects and risk stratification of acute coronary syndromes without ST-segment elevation]Nicolas Danchin
European Heart Journal|December 20, 2022
Improved long-term survival after acute myocardial infarction: the success of comprehensive care from the acute stage to the long termNicolas Danchin
The American Journal of Cardiology|August 26, 2006
Clinical benefits of a metabolic approach with trimetazidine in revascularized patients with anginaNicolas Danchin
Pageof 44

Showing results (11-20 of 432) with videos related to

Sort By:
Pageof 44
European Heart Journal|September 2, 2009
Still a long way to go to defeating atherosclerotic disease: a call to arms!Nicolas Danchin
Archives of Cardiovascular Diseases|March 24, 2009
Should angiotensin-converting enzyme inhibitors be used in all patients with coronary artery disease or restricted to those with a history of myocardial infarction or myocardial revascularization?Nicolas Danchin
Heart (British Cardiac Society)|November 4, 2022
Missed opportunities in secondary prevention with statinsNicolas Danchin
European Heart Journal|February 17, 2005
Percutaneous coronary intervention following intravenous fibrinolytic therapy: should it be a must?Nicolas Danchin
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 12, 2018
What should interventional cardiologists do for patients with prediabetes?Nicolas Danchin
Annales De Cardiologie Et D'Angeiologie|January 18, 2006
[Drug combinations and cardiovascular prevention]Nicolas Danchin
JACC. Cardiovascular Interventions|October 24, 2009
Systems of care for ST-segment elevation myocardial infarction: impact of different models on clinical outcomesNicolas Danchin
La Revue Du Praticien|May 17, 2003
[Clinical aspects and risk stratification of acute coronary syndromes without ST-segment elevation]Nicolas Danchin
European Heart Journal|December 20, 2022
Improved long-term survival after acute myocardial infarction: the success of comprehensive care from the acute stage to the long termNicolas Danchin
The American Journal of Cardiology|August 26, 2006
Clinical benefits of a metabolic approach with trimetazidine in revascularized patients with anginaNicolas Danchin
Pageof 44